COMMUNIQUÉS West-GlobeNewswire

Adamas Announces Data Presentations at the 71st American Academy of Neurology Annual Meeting

07/05/2019 - 03:39

EMERYVILLE, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system (CNS) disorders [...]

Dr. James Chappuis Atlanta´s Most-Coveted Spinal Specialist

07/05/2019 - 01:23

James L. Chappuis MD FACS Atlanta, Georgia, May 06, 2019 (GLOBE NEWSWIRE) -- For the last 28 years, Dr. James Chappuis an Atlanta based Spinal specialist has been a visionary in his field, Dr. James L. Chappuis FACS [...]

Protech Home Medical Corp Disclosure Regarding Cyberscam Incident

07/05/2019 - 00:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE ‎UNITED STATES CINCINNATI, May 06, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“ Protech ” or the “ Company ”) (TSXV: ‎PTQ), [...]

Aleafia Health Provides Corporate By-law Update

06/05/2019 - 23:16

TORONTO, May 06, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) Board of Directors have approved an advance notice by‑law, the purpose of which [...]

The Ensign Group, Inc. Announces Home Health, Hospice and Senior Living Spin-off

06/05/2019 - 23:07

MISSION VIEJO, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care and [...]

FibroGen to Report First Quarter 2019 Financial Results

06/05/2019 - 23:00

SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will report first quarter 2019 financial results on Thursday, May 9, 2019 after market close, and will host a [...]

aTyr Pharma to Announce First Quarter 2019 Results on May 13th

06/05/2019 - 22:58

Company to host conference call and webcast at 5pm EDT / 2pm PDT SAN DIEGO, May 06, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of [...]

XOMA Reports First Quarter 2019 Financial Results and Operating Highlights

06/05/2019 - 22:30

Acquired rights to potential milestone and royalty payments associated with five hematology assets Received $5.5 million milestone payment Added Barbara Kosacz to XOMA’s Board of Directors Current cash balance [...]

Osmotica Pharmaceuticals plc Announces Positive Topline Results of Phase III Clinical Trials of RVL-1201 (“RVL”) for Acquired Blepharoptosis (ptosis or droopy eyelid)

06/05/2019 - 22:30

- Second Phase III Study 202 Meets Primary Endpoint; Provides Additional Evidence of Efficacy and Safety - - Long-term Phase III Study 203 Provides Additional Evidence of Safety - - Company to Host Conference Call on [...]

Update to Natus Medical First Quarter 2019 Financial Results

06/05/2019 - 22:30

GAAP loss per share changed to $0.89 from $0.74 No change to non-GAAP earnings per share PLEASANTON, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) (the “Company” or “Natus”), a [...]

Better Choice Company Inc. Announces Closing of $17.2 Million Private Placement, a 16.2% Increase From the Amount Previously Announced

06/05/2019 - 22:30

BROOKLYN, N.Y., May 06, 2019 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (OTCQB: BTTR) (the “Company”) today announced that it has closed its previously announced private placement for aggregate gross proceeds of [...]

Amedisys Celebrates More Than 7,000 Nurses During National Nurses Week

06/05/2019 - 22:30

BATON ROUGE, La., May 06, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, celebrates National Nurses Week by honoring more than 7, [...]

Otonomy Reports First Quarter 2019 Financial Results and Provides Corporate Update

06/05/2019 - 22:17

OTO-313 Phase 1/2 trial in tinnitus initiated; results expected in first half of 2020 OTIPRIO ® co-promotion agreement completed with Glenmark Therapeutics OTIVIDEX™ Phase 3 trial in Ménière’s disease on track for [...]

Alpha Pro Tech, Ltd. Announces Revenue of $12.3 Million, $0.09 in EPS, for the First Quarter of 2019

06/05/2019 - 22:15

Revenue in the first quarter of 2019 was $12.3 million, an increase of 7.5% compared to $11.4 million in the first quarter of 2018. Income from operations increased to 8.1% of net sales in the first quarter of 2019, up [...]

LeMaitre Vascular to Present at Upcoming Investor Conferences

06/05/2019 - 22:15

BURLINGTON, Mass., May 06, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two investor conferences in May. David Roberts, President, is scheduled to [...]

Teligent, Inc. Announces First Quarter 2019 Results

06/05/2019 - 22:15

BUENA, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2019 [...]

Progenics Pharmaceuticals Issues Statement Regarding Velan Capital

06/05/2019 - 22:15

Progenics Board Deeply Committed to Enhancing Value for all Shareholders Repeated Efforts to Engage Meaningfully with Velan Rebuffed No Shareholder Action Required at this Time NEW YORK, May 06, 2019 (GLOBE NEWSWIRE [...]

TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

06/05/2019 - 22:15

ANDOVER, Mass., May 06, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart [...]

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress

06/05/2019 - 22:11

SAN DIEGO, May 06, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes [...]